CSPC PHARMACEUTICAL GROUP LIMITED 1093 1 5,342,470 5,075,665 +5.3% 653,852 434,655 +50.4% 2 117,330 3 (53,187) (36,784) 600,665 515,201 +16.6% 10.17 9.30 +9.4% 10.07 8.81 +14.3% 1
1. 381,200,000 4,694,470,000 13.8% 2. 117,330,000 3. 53,187,000 36,784,000 2
3 5,342,470 5,075,665 (3,321,420) (3,534,056) 2,021,050 1,541,609 90,530 92,997 (846,327) (659,707) (302,889) (308,628) (160,918) (83,901) 801,446 582,370 (29,231) (36,636) (526) (11,420) 117,330 4 771,689 651,644 5 (162,263) (123,814) 609,426 527,830 3
(216,076) 76,642 (444) 175 (216,520) 76,817 392,906 604,647 600,665 515,201 8,761 12,629 609,426 527,830 386,683 589,598 6,223 15,049 392,906 604,647 7 10.17 9.30 10.07 8.81 4
4,934,087 4,961,171 527,489 547,754 125,232 128,438 116,863 127,597 17,067 18,038 1,705 1,705 34,456 43,071 5,756,899 5,827,774 2,032,478 1,855,188 8 2,105,510 2,029,961 8 935,524 982,437 114,491 122,137 99,518 91,519 15,451 16,909 388 226 405 438 3,428 90,081 82,779 998,984 1,187,751 6,392,830 6,372,773 9 2,507,867 2,303,199 9 345,105 273,397 12,628 47,607 3,166 2,007 195,856 475,179 87,046 77,116 751,504 659,946 3,903,172 3,838,451 2,489,658 2,534,322 8,246,557 8,362,096 5
554,380 680,120 42,148 33,117 104,014 52,059 700,542 765,296 7,546,015 7,596,800 9,819,731 558,636 (2,399,068) 6,893,984 7,420,663 7,452,620 125,352 144,180 7,546,015 7,596,800 6
1. 34 16 Hony Capital Fund III, L.P. 50% 2. 10 12 27 32 36 39 21 3. 7
(a) (b) (c) (d) C C 3,189,617 1,173,402 656,137 323,314 5,342,470 5,342,470 23,676 4,273 3,627 31,576 (31,576) 3,189,617 1,197,078 660,410 326,941 5,374,046 (31,576) 5,342,470 789,265 75,250 (18,464) 58,100 904,151 2,873 (105,578) 801,446 (29,231) (526) 771,689 8
C 2,761,971 1,437,602 553,446 322,646 5,075,665 5,075,665 94,185 1,549 2,834 98,568 (98,568) 2,761,971 1,531,787 554,995 325,480 5,174,233 (98,568) 5,075,665 633,997 23,110 (86,847) 86,084 656,344 23,124 (97,098) 582,370 (36,636) (11,420) 117,330 651,644 9
4. 9,790 4,167 7,704 6,873 294,000 353,695 (9,873) 17,649 (2,828) (672) 1,344 2,455 155,631 83,847 53,187 36,784 ii (67,150) (63,212) (2,873) (3,175) (i) (ii) 5. 141,093 109,342 3,268 3,405 144,361 112,747 17,902 11,067 162,263 123,814 10
6. 16.5% 25% 15% 10% 10% 13,475,000 9,724,000 8 10 472,641,000 382,542,000 11
7. 600,665 515,201 5,908,018 5,537,570 312,750 59,249 5,967,267 5,850,320 774,029,472.70 6,037,429,887.06 86,003,274.70 670,825,542.66 12
8. 1,773,084 1,720,828 (2,525) (1,588) 1,770,559 1,719,240 165,200 126,911 20,479 12,846 50,961 62,879 98,311 108,085 2,105,510 2,029,961 90 0 90 1,577,955 1,484,861 91 180 160,794 174,391 181 365 26,178 11,377 365 5,632 48,611 1,770,559 1,719,240 180 180 13
9. 1,124,121 935,534 80,206 37,313 4,363 27,727 560,157 548,376 87,221 182,235 377,662 280,999 145,600 141,077 52,672 73,000 23,739 45,999 52,126 30,939 2,507,867 2,303,199 0 90 811,807 658,963 91 180 111,728 78,391 180 200,586 198,180 1,124,121 935,534 180 14
53.42 6.01 12.99 49.3% 15
1.12, GMP GSP 16
C C 170 14 41 29 14 5-1 re4 2 1.1 SKLB1028 DBPR-108 SKLB1028DBPR- 108DBPR-108 17
23 8 15 12 ANDA 2 FDA ANDA 9 FDA FDA 3 FDA 4 4 4 ANDA 10.10 63 57 105 111 1.6 1.7 3.97 18
10.89 12.71 13.06 13.40 7.52 5.54 2.9% 1% 34% 19% 47% C C 22,500,000 20,000,000 2,500,000 2,200,000 2,200,000 19
10,391 14 A.2.1 A.5.1 A.2.1 A.5.1 A.5.1 A.5.1 3.10A 3.10A (10) (1) (5) 3.10A 20
21